Akut mieloid leukémia (AML): vizsgálatok itt: Mexikó

1 trial · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

  Where

  Mexico City

  Életkor

  18 év and over

  People

  600 worldwide

  Run by

  Janssen Research & Development, LLC

  See details and how to joinNCT06852222 · EU 2024-520154-38-00